Search alternatives:
points decrease » point decrease (Expand Search), point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 points » _ points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
points decrease » point decrease (Expand Search), point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 points » _ points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
-
41
-
42
-
43
-
44
-
45
-
46
-
47
Rac1 activity decreases in the presence of DECMA-1 and E-cadherin:Fc in 3-D cell aggregates.
Published 2011“…<p>3-D MDCK cell aggregates were incubated with 10 µg/ml of DECMA-1 monovalent Fab' fragments (A), or 10 µg/ml of purified E-cadherin:Fc extracellular domain (E), or 10 µg/ml of Fc protein (I) for the indicated times. …”
-
48
-
49
-
50
-
51
-
52
-
53
<i>roh</i> mutation results in Rh1 decrease.
Published 2015“…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
-
54
mGluR5 receptor decreased glycinergic currents.
Published 2019“…<p>(<b>A–B</b>) Bath perfusion of DHPG for 3 min reduced GlyR-IPSCs (<b>A</b>; 70.2 ± 4.2% of baseline at 15–20 min post-DHPG, <i>t</i>[16] = 6.707, <i>p</i> < 0.001, paired Student <i>t</i> test), but not GABA<sub>A</sub>-receptor–mediated IPSCs (<b>B</b>; 102.9 ± 3.3% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 0.347, <i>p</i> = 0.743) in spinal slices of mice. …”
-
55
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
56
-
57
-
58
-
59
-
60